CODX
Co-Diagnostics, Inc. Common Stock
NASDAQ: CODX · HEALTHCARE · MEDICAL DEVICES
$1.53
-6.13% today
Updated 2026-04-29
Market cap
$5.94M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-35.25
Dividend yield
—
52W range
$1 – $47
Volume
1.5M
Co-Diagnostics, Inc. Common Stock (CODX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,902.00%
ROE
-125.90%
ROA
-44.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-1.05M | — | — | — |
| 2015 | $10000.00 | $-2.04M | 100.00% | -19,679.79% | -20,431.68% |
| 2016 | $0.00 | $-1.93M | — | — | — |
| 2017 | $7662.00 | $-6.96M | 96.06% | -59,567.57% | -90,827.88% |
| 2018 | $39911.00 | $-6.27M | 76.47% | -15,328.65% | -15,714.27% |
| 2019 | $214974.00 | $-6.20M | 47.70% | -2,741.61% | -2,882.00% |
| 2020 | $74.55M | $42.48M | 77.75% | 55.93% | 56.98% |
| 2021 | $97.89M | $36.66M | 88.18% | 47.06% | 37.45% |
| 2022 | $34.22M | $-14.24M | 83.98% | -78.85% | -41.61% |
| 2023 | $6.81M | $-35.33M | 38.57% | -626.92% | -518.68% |
| 2024 | $3.92M | $-37.64M | 74.48% | -1,023.75% | -961.37% |
| 2025 | $622489.00 | $-46.90M | 64.28% | -5,025.53% | -7,533.62% |